Damora Therapeutics, Inc.(DMRA)

$26.01—

Chart

Damora Therapeutics, Inc.(DMRA)

NASDAQ

$26.01—

Chart Studio

DMRA(DMRA)

DMRA

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

DMRA 11 articles

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com·Jun 1

Damora Therapeutics: Well-Funded Moonshot For CALR Mutations

seekingalpha.com·May 27

Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

globenewswire.com·May 12

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com·May 1

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Given Consensus Recommendation of “Moderate Buy” by Analysts

defenseworld.net·Apr 23

What Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now?

zacks.com·Apr 20

How Much Upside is Left in DAMORA THERAPEU (DMRA)? Wall Street Analysts Think 73.1%

zacks.com·Apr 10

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com·Mar 30

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Given Average Rating of “Moderate Buy” by Analysts

defenseworld.net·Mar 29

Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

globenewswire.com·Mar 23

Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

globenewswire.com·Mar 19

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance